• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET XL 360 SOFT 7MM X 20CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET XL 360 SOFT 7MM X 20CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0036127200
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/02/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during the coil embolization procedure of an unruptured aneurysm in the anterior communicating artery, a stent was implanted using the trans cell technique and a microcatheter was placed in the aneurysm.Embolization was started with the subject coil as the framing coil.For the repositioning of the subject coil to engage with the aneurysm, the delivery wire was retracted to pull the subject coil back to the microcatheter.While about two loops of the subject coil were out of the microcatheter, it was found that the subject coil was not seen under the fluoroscopy.When the delivery wire of the subject coil was pulled carefully, it was found that the subject coil was prematurely detached.The entire microcatheter was removed from the body, and the prematurely detached subject coil was removed out of the microcatheter.The physician replaced it with a new device and continued the procedure without clinical consequences to the patient.
 
Additional Manufacturer Narrative
Due to the automated manufacturing execution system (mes) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, visual and functional testing as well as physical analysis cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Per the event description the main coil detached inside the microcatheter during repositioning.There were no anomalies noted to the device prior to use and appears to have been prepared per the dfu.While there are a number of potential causes for the reported issues, because a review of available information failed to identify a definitive cause and the device was not returned for analysis, an assignable cause of undeterminable was assigned to this complaint.
 
Event or Problem Description
It was reported that during the coil embolization procedure of an unruptured aneurysm in the anterior communicating artery, a stent was implanted using the trans cell technique and a microcatheter was placed in the aneurysm.Embolization was started with the subject coil as the framing coil.For the repositioning of the subject coil to engage with the aneurysm, the delivery wire was retracted to pull the subject coil back to the microcatheter.While about two loops of the subject coil were out of the microcatheter, it was found that the subject coil was not seen under the fluoroscopy.When the delivery wire of the subject coil was pulled carefully, it was found that the subject coil was prematurely detached.The entire microcatheter was removed from the body, and the prematurely detached subject coil was removed out of the microcatheter.The physician replaced it with a new device and continued the procedure without clinical consequences to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET XL 360 SOFT 7MM X 20CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key20191726
Report Number3008881809-2024-00417
Device Sequence Number6792631
Product Code HCG
UDI-Device Identifier07613327004632
UDI-Public(01)07613327004632(17)261125(10)24633124
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K123377
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberM0036127200
Device Lot Number24633124
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/02/2024
Supplement Date Received by Manufacturer09/30/2024
Initial Report FDA Received Date09/11/2024
Supplement Report FDA Received Date10/21/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/27/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NEUROFORM ATLAS STENT (STRYKER).; SL-10 MICROCATHETER (STRYKER).
Patient Age74 YR
Patient SexFemale
-
-